CL2008003481A1 - Peptide molecule with antimicrobial activity comprising cecropin doublet formed by its sequence linked to its inverted sequence; method of obtaining; use of said molecule to prevent or treat microbial diseases; pharmaceutical composition that includes it; crude extract thereof; use of said crude extract - Google Patents

Peptide molecule with antimicrobial activity comprising cecropin doublet formed by its sequence linked to its inverted sequence; method of obtaining; use of said molecule to prevent or treat microbial diseases; pharmaceutical composition that includes it; crude extract thereof; use of said crude extract

Info

Publication number
CL2008003481A1
CL2008003481A1 CL2008003481A CL2008003481A CL2008003481A1 CL 2008003481 A1 CL2008003481 A1 CL 2008003481A1 CL 2008003481 A CL2008003481 A CL 2008003481A CL 2008003481 A CL2008003481 A CL 2008003481A CL 2008003481 A1 CL2008003481 A1 CL 2008003481A1
Authority
CL
Chile
Prior art keywords
crude extract
molecule
sequence
cecropin
obtaining
Prior art date
Application number
CL2008003481A
Other languages
Spanish (es)
Inventor
Marshall Sergio
Arenas Gloria
Diaz Mauricio
Nilo Luis
Olivares Jorge
Original Assignee
Pontificia Universidad Catolica De Valparaiso
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pontificia Universidad Catolica De Valparaiso filed Critical Pontificia Universidad Catolica De Valparaiso
Priority to CL2008003481A priority Critical patent/CL2008003481A1/en
Publication of CL2008003481A1 publication Critical patent/CL2008003481A1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Molécula peptídica con actividad antimicrobiana que comprende un doblete de cecropina a; método de obtención de dicha molécula; uso de dicha molécula para prevenir o tratar enfermedades microbianas; composición farmacéutica que comprende dicha molécula; extracto crudo de la molécula peptídica; uso de dicho extracto crudo.Peptide molecule with antimicrobial activity comprising a doublet of cecropin a; method of obtaining said molecule; use of said molecule to prevent or treat microbial diseases; pharmaceutical composition comprising said molecule; crude extract of the peptide molecule; use of said crude extract.

CL2008003481A 2008-11-21 2008-11-21 Peptide molecule with antimicrobial activity comprising cecropin doublet formed by its sequence linked to its inverted sequence; method of obtaining; use of said molecule to prevent or treat microbial diseases; pharmaceutical composition that includes it; crude extract thereof; use of said crude extract CL2008003481A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CL2008003481A CL2008003481A1 (en) 2008-11-21 2008-11-21 Peptide molecule with antimicrobial activity comprising cecropin doublet formed by its sequence linked to its inverted sequence; method of obtaining; use of said molecule to prevent or treat microbial diseases; pharmaceutical composition that includes it; crude extract thereof; use of said crude extract

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2008003481A CL2008003481A1 (en) 2008-11-21 2008-11-21 Peptide molecule with antimicrobial activity comprising cecropin doublet formed by its sequence linked to its inverted sequence; method of obtaining; use of said molecule to prevent or treat microbial diseases; pharmaceutical composition that includes it; crude extract thereof; use of said crude extract

Publications (1)

Publication Number Publication Date
CL2008003481A1 true CL2008003481A1 (en) 2008-12-26

Family

ID=51399110

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2008003481A CL2008003481A1 (en) 2008-11-21 2008-11-21 Peptide molecule with antimicrobial activity comprising cecropin doublet formed by its sequence linked to its inverted sequence; method of obtaining; use of said molecule to prevent or treat microbial diseases; pharmaceutical composition that includes it; crude extract thereof; use of said crude extract

Country Status (1)

Country Link
CL (1) CL2008003481A1 (en)

Similar Documents

Publication Publication Date Title
CR11472A (en) 4- (4-CIANO-2-TIOARIL) DIHYDROPIRIMIDINONES AND ITS USE
CO6680687A2 (en) Dual variable domain immunoglobins capable of binding to il 1 beta and il-17, pharmaceutical compositions and protein binding conjugates thereof
CO2018000104A2 (en) Antibody molecules that bind to cd22
PA8772101A1 (en) IMIDAZOL-TRIAZOLOPIRIMIDINAS REPLACED
CO6410314A2 (en) IL-17 UNION PROTEINS
CL2011002835A1 (en) Compounds derived from 7-aza-spiro [3.5] nonane-7-carboxylates; preparation procedure; intermediate compounds; pharmaceutical composition; and its use to treat acute or chronic pain of neurogenic types, associated with inflammatory diseases, among others.
GT200900230A (en) 4-ARIL-1,4-DIHIDRO-1,6-NAFTIRIDINAMIDES REPLACED AND USE
CR20160222U (en) SOLID FORMS OF ACID {[- (3- CHLOROPHENYL) -3- HYDROXIPIRIDIN -2-CARBONIL] AMINO} ACETIC, COMPOSITIONS, AND USES OF THE SAME
GT201200313A (en) 5-FLUORO-1H-REPLACED PIRAZOLOPIRIDINES AND ITS USE
HN2008001720A (en) ARILIMIDAZOLONAS AND ARILTRIAZOLONAS REPLACED AS INHIBITORS OF VASOPRESINE RECEPTORS
CO2018000410A2 (en) Antibody molecules that bind to cd79
GT201000023A (en) NEW DERIVATIVES OF 6-TRIALZOLOPIRIDACINA-SULFANIL BENZOTIAZOL AND BENCIMIDAZOL, ITS PREPARATION PROCEDURE, ITS APPLICATION AS MEDICATIONS, PHARMACEUTICAL COMPOSITIONS AND NEW MAIN USE AS MET INHIBITORS.
UY32456A (en) FAMOUS COMPOSITION, PHARMACEUTICAL FORM, PROCEDURE FOR PREPARATION, METHODS OF TREATMENT
CO2017009433A2 (en) Specific proteins for pyoverdin and pyoquelin
CR20110509A (en) PHARMACEUTICAL COMPOSITION
CL2010001368A1 (en) Compounds derived from 1,3-thiazine; pharmaceutical composition that includes it; Useful for inhibiting beta-secretase
ECSP10010548A (en) COMPOSITIONS AND METHODS OF PREPARATION AND USE OF THE SAME
CL2009001484A1 (en) Glycinate salt of metformin; pharmaceutical composition comprising the salt; and its use to treat hyperglycemia.
BRPI0906478B8 (en) anti-nr10 antibody, its use and pharmaceutical composition comprising it
PA8784101A1 (en) OXAZOLIDINONES REPLACED AND ITS USE
PA8784301A1 (en) OXAZOLIDINONES REPLACED AND ITS USE
PA8806501A1 (en) TRIAZOLOTRIAZINAS AND TRIAZOLOPIRAZINAS AND ITS USE
BR112013000840A2 (en) method for enhancing the effect of potentiated activated form of antibody to biological endogenous molecule, pharmaceutical composition and use of combination of endogenous biological molecule with potentiated activated form of antibody to endothelial synthase.
HN2011003102A (en) SUBSTITUTED PIPERIDINS
UY32408A (en) ANTI-INFLAMMATORY MACROLIDO